EUVIMEDEUVIMED entdecken
Crossref

High-Throughput Screening of a Lipid Nanoparticle (LNP) Library Identifies Lead Formulations for CRISPR-Cas9 Ribonucleoprotein Delivery and Gene Editing

Yu Wang, Amin Haghighat Naeini iD, Nishant Kumar, Ming Zhao iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c11615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Yu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas66047, United States. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Nanoparticles, Lipids. Die Arbeit nennt 58 Literaturangaben. Gefördert von: University of Kansas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delivery of CRISPR-Cas9 ribonucleoprotein (RNP) using synthetic materials can bypass the host translational machinery and limit the duration of genomic exposure, minimizing the risk of off-target mutations. Despite their advantages, lipid nanoparticle (LNP) platforms for CRISPR-Cas9 RNP delivery that achieve highly efficient editing at low doses remain limited. In the present study, we developed a library of ionizable lipids (ILs) and corresponding LNPs to enhance the delivery and editing efficiencies of CRISPR-Cas9 RNP complexes. Following comprehensive in vitro screening and formulation optimization, an optimal LNP candidate containing the C12A9 IL (denoted as LNPC12A9) was identified that achieved ∼90% EGFP disruption in HEK293T-EGFP cells at an RNP concentration of 30 nM and ∼60% at 15 nM. The editing performance was consistently observed at an RNP concentration of 15 nM when editing the Gcgr and HPRT1 genes across multiple hepatic cell lines. Moreover, coencapsulation of RNP and a single-stranded oligodeoxynucleotide (ssODN) template for homology-directed repair (HDR) within LNPC12A9 induced an HDR rate of 37.8%. Systemic administration of LNPC12A9 into C57BL/6J mice led to liver tropism and a total hepatic Pcsk9 gene disruption rate of 1.39%. In conclusion, this study provides insights into the construction of an LNP platform to improve the delivery efficiency of CRISPR-Cas9 RNP, thereby facilitating the development of LNPs for safe, precise, and tissue-specific Cas9 RNP-based genome editing therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsNanoparticlesLipidsRibonucleoproteinsHumansAnimalsMiceHEK293 CellsHigh-Throughput Screening AssaysLiposomes

Stichwörter der Autor:innen

CRISPR-Cas9 ribonucleoprotein deliverygenome editinghigh-throughput screeninghomology-directed repair (HDR)lipid nanoparticle

Substanzen

LipidsRibonucleoproteinsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas66047, United States.

ORCID-Profile: Amin Haghighat Naeini, Ming Zhao

Förderung

  • University of Kansas

Zitieren

APA

Wang, Y., Haghighat Naeini, A., Kumar, N., & Zhao, M. (2026). High-Throughput Screening of a Lipid Nanoparticle (LNP) Library Identifies Lead Formulations for CRISPR-Cas9 Ribonucleoprotein Delivery and Gene Editing. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c11615

Vancouver

Wang Y, Haghighat Naeini A, Kumar N, Zhao M. High-Throughput Screening of a Lipid Nanoparticle (LNP) Library Identifies Lead Formulations for CRISPR-Cas9 Ribonucleoprotein Delivery and Gene Editing. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c11615

BibTeX
@article{Wang2026,
  author = {Wang, Yu and Haghighat Naeini, Amin and Kumar, Nishant and Zhao, Ming},
  title = {High-Throughput Screening of a Lipid Nanoparticle (LNP) Library Identifies Lead Formulations for CRISPR-Cas9 Ribonucleoprotein Delivery and Gene Editing},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c11615}
}
Kostenlos starten →